We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIOSW
1726
CALL
DELISTED
BioPlus Acquisition Corp. Warrants
BIOSW
$1.95M ﹤0.01%
190,150
B
1727
Barrick Mining
B
$61.5B
$1.95M ﹤0.01%
+113,708
New +$1.81M
BR icon
1728
Broadridge
BR
$18.3B
$1.95M ﹤0.01%
14,559
-37,280
-72% -$5.3M
KR icon
1729
CALL
Kroger
KR
$36.3B
$1.95M ﹤0.01%
43,800
-202,300
-82% -$9.29M
BLDR icon
1730
Builders FirstSource
BLDR
$7.93B
$1.95M ﹤0.01%
30,092
+16,656
+124% +$1.04M
JAZZ icon
1731
Jazz Pharmaceuticals
JAZZ
$16.1B
$1.94M ﹤0.01%
+12,198
New +$1.79M
AEAEW
1732
CALL
DELISTED
AltEnergy Acquisition Corp Warrant
AEAEW
$1.93M ﹤0.01%
189,034
ECH icon
1733
iShares MSCI Chile ETF
ECH
$1B
$1.93M ﹤0.01%
71,121
-15,800
-18% -$406K
BOCN
1734
DELISTED
Blue Ocean Acquisition Corp Class A Ordinary Shares
BOCN
$1.93M ﹤0.01%
187,310
GHIXW
1735
CALL
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$1.91M ﹤0.01%
192,845
-407,151
-68% -$101K
EL icon
1736
CALL
Estee Lauder
EL
$30.7B
$1.91M ﹤0.01%
+7,700
New +$1.72M
OMF icon
1737
PUT
OneMain Financial
OMF
$7.19B
$1.9M ﹤0.01%
+57,100
New +$2.02M
SBUX icon
1738
CALL
Starbucks
SBUX
$118B
$1.89M ﹤0.01%
19,100
+17,000
+810% +$1.6M
PMGMW
1739
CALL
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.89M ﹤0.01%
186,768
-163,227
-47% -$25.4K
CVIIW
1740
CALL
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$1.89M ﹤0.01%
189,261
STZ icon
1741
PUT
Constellation Brands
STZ
$22.5B
$1.88M ﹤0.01%
+8,100
New +$1.94M
BBJP icon
1742
JPMorgan BetaBuilders Japan ETF
BBJP
$17.1B
$1.87M ﹤0.01%
+41,714
New +$1.83M
ERIE icon
1743
Erie Indemnity
ERIE
$12.7B
$1.87M ﹤0.01%
7,514
+6,372
+558% +$1.64M
RFAC
1744
DELISTED
RF Acquisition Corp. Class A Common Stock
RFAC
$1.87M ﹤0.01%
184,665
FDL icon
1745
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.9B
$1.86M ﹤0.01%
+51,000
New +$1.84M
TLS icon
1746
Telos
TLS
$344M
$1.86M ﹤0.01%
+365,274
New +$2.42M
LEGN icon
1747
Legend Biotech
LEGN
$3.68B
$1.85M ﹤0.01%
+37,125
New +$1.8M
SRRK icon
1748
Scholar Rock
SRRK
$5.92B
$1.85M ﹤0.01%
204,385
-16,894
-8% -$136K
TGAAW
1749
CALL
DELISTED
Target Global Acquisition I Corp. Warrant
TGAAW
$1.85M ﹤0.01%
180,264
HLNE icon
1750
Hamilton Lane
HLNE
$3.91B
$1.84M ﹤0.01%
28,850
-179
-0.6% -$11.9K

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.